X

Vous n'êtes pas connecté

Rubriques :

Maroc Maroc - NEWS.MEDICAL.NET - A la Une - 17/Jan 07:27

Unveiling the metabolic pathways of Fusobacterium nucleatum in OSCC

A recent study has made significant strides in uncovering how the oral microbiome, particularly the bacterium Fusobacterium nucleatum, plays a crucial role in the progression of oral squamous cell carcinoma (OSCC). By identifying key interactions between this common oral bacterium and host cells, the research has unveiled important metabolic pathways and mechanisms that may serve as potential therapeutic targets.

Articles similaires

Sorry! Image not available at this time

Cutaneous Squamous Cell Carcinoma Pipeline Drugs Insights Report 2025: Promising Drugs and MOA Innovations Reshape ...

wn.com - 07/Dec 11:26

DelveInsight’s, “Cutaneous Squamous Cell Carcinoma Pipeline Insight 2025” report provides comprehensive insights about 45+ companies...

Sorry! Image not available at this time

Cutaneous Squamous Cell Carcinoma Pipeline Drugs Insights Report 2025: Promising Drugs and MOA Innovations Reshape ...

wn.com - 07/Dec 11:26

DelveInsight’s, “Cutaneous Squamous Cell Carcinoma Pipeline Insight 2025” report provides comprehensive insights about 45+ companies...

Sorry! Image not available at this time

'The tattoo on my arm is now on my tongue after cancer treatment'

bbc - 06/Dec 07:17

Harriet Trewhitt, 21, was diagnosed with stage 2 squamous cell carcinoma earlier this year.

Sorry! Image not available at this time

TV presenter Adrian Chiles reveals skin cancer diagnosis

news.stv.tv - 04/Dec 16:00

The presenter said he had been successfully treated for a squamous cell carcinoma, a type of skin cancer.

Sorry! Image not available at this time

FDA Approves Updated Label for Unloxcyt

drugs.com - 03/Dec 16:12

WEDNESDAY, Dec. 3, 2025 -- The U.S. Food and Drug Administration has approved an updated label for Unloxcyt (cosibelimab-ipdl) for the treatment of...

Sorry! Image not available at this time

FDA Approves Updated Label for Unloxcyt

drugs.com - 03/Dec 16:12

WEDNESDAY, Dec. 3, 2025 -- The U.S. Food and Drug Administration has approved an updated label for Unloxcyt (cosibelimab-ipdl) for the treatment of...

Sorry! Image not available at this time

Toripalimab Presents Long-Term Survival Benefits as 1st-line Treatment for Advanced Nasopharyngeal Carcinoma and Esophageal Squamous Cell Carcinoma Patients

financialpost.com - 06/Dec 03:13

Long-term OS follow-up analysis of JUPITER-02 demonstrates significantly better and clinically meaningful improvement with toripalimab plus...

Sorry! Image not available at this time

Toripalimab Presents Long-Term Survival Benefits as 1st-line Treatment for Advanced Nasopharyngeal Carcinoma and Esophageal Squamous Cell Carcinoma Patients

financialpost.com - 06/Dec 03:13

Long-term OS follow-up analysis of JUPITER-02 demonstrates significantly better and clinically meaningful improvement with toripalimab plus...

Sorry! Image not available at this time

The Biggest Breakthroughs in Cell Biology in 2025

wn.com - 09/Dec 05:04

As 2025 comes to a close, the editors at The Scientist asked researchers to reflect on the biggest breakthroughs in cell biology this year. They named...

Sorry! Image not available at this time

The Biggest Breakthroughs in Cell Biology in 2025

wn.com - 09/Dec 05:04

As 2025 comes to a close, the editors at The Scientist asked researchers to reflect on the biggest breakthroughs in cell biology this year. They named...

Les derniers communiqués